| scholarly article | Q13442814 |
| P2093 | author name string | Margolis HC | |
| Yokoyama S | |||
| Nakagawa Y | |||
| Kaiser ET | |||
| Kézdy FJ | |||
| Coe FL | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | calcium oxalate | Q412399 |
| P304 | page(s) | 3936-3944 | |
| P577 | publication date | 1981-04-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium | |
| P478 | volume | 256 |
| Q70470330 | Adsorption of molecules of biological interest onto hydroxyapatite |
| Q41812136 | An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine |
| Q34598492 | Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile |
| Q35908757 | Characterization of calcium-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin with vanadyl ions: electron paramagnetic resonance and electron nuclear double resonance spectroscopy |
| Q40665743 | Effects of Tamm-Horsfall protein on the protection of MCDK cells from oxalate induced free radical injury |
| Q41193178 | Glycosaminoglycans, proteins, and stone formation: adult themes and child's play |
| Q70163732 | Inhibition of calcium oxalate monohydrate (COM) crystal growth by pyrophosphate, citrate and rat urine |
| Q44587987 | Inhibition of calcium phosphate precipitation by human salivary statherin: structure-activity relationships |
| Q70619639 | Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization |
| Q40922613 | Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid |
| Q33315124 | Mass spectroscopic characteristics of low molecular weight proteins extracted from calcium oxalate stones: preliminary study |
| Q27027510 | Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators |
| Q33580480 | Reflections on stones. |
| Q74284754 | Role of biomolecules from human renal stone matrix on COM crystal growth |
| Q57492018 | The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease |
| Q40609165 | The effect of ions at the surface of calcium oxalate monohydrate crystals on cell-crystal interactions |
| Q72691836 | The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin |
| Q41535988 | Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation |
| Q28362644 | Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis |
Search more.